Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4698023010 | Drotaverine and mefenamic acid only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4698024016 | Product containing only drotaverine and mefenamic acid in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Drotaverine and mefenamic acid only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Drotaverine and mefenamic acid only product in oral dose form | Has active ingredient | Drotaverine (substance) | true | Inferred relationship | Some | 1 | |
| Drotaverine and mefenamic acid only product in oral dose form | Is a | Drotaverine and mefenamic acid only product | true | Inferred relationship | Some | ||
| Drotaverine and mefenamic acid only product in oral dose form | Is a | Drotaverine- and mefenamic acid-containing product in oral dose form | true | Inferred relationship | Some | ||
| Drotaverine and mefenamic acid only product in oral dose form | Has active ingredient | Mefenamic acid (substance) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely drotaverine hydrochloride 80 milligram and mefenamic acid 250 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Drotaverine and mefenamic acid only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR